Optimal PEEP in Pediatric Patients Under 17 Years of Age.

February 3, 2023 updated by: Seoul National University Hospital

Determination of Optimal Positive End-expiratory Pressure in Prone Position During General Anesthesia Using Electrical Impedance Tomography in Pediatric Patient Under 17 Years of Age

This study aimed to investigate the differences in positive end-expiratory pressure titration in the supine and prone positions by age in pediatric patients under 17 years of age who received general anesthesia and then evaluate the hemodynamic stability.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 16 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients who are scheduled to undergo general anesthesia in the prone position
  • patients who are in age under 17 years

Exclusion Criteria:

  • had cyanosis or chronic respiratory failure
  • had respiratory distress syndrome or bronchopulmonary dysplasia
  • had laryngotracheal diseases
  • had pulmonary hypertension
  • receiving oxygen therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Experimental arm
All patients will be enrolled in the same arm.
Titrating positive end-expiratory pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Optimal positive end-expiratory pressure (PEEP)
Time Frame: 10 minutes after intubation
result of decremental PEEP trial
10 minutes after intubation
Optimal positive end-expiratory pressure (PEEP)
Time Frame: 60 minutes after prone positioning
result of decremental PEEP trial
60 minutes after prone positioning

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impedance tidal variation
Time Frame: 10 minutes after intubation
respiratory parameters measured by Electrical Impedance Tomography (EIT) device
10 minutes after intubation
Impedance tidal variation
Time Frame: 60 minutes after prone positioning
respiratory parameters measured by EIT device
60 minutes after prone positioning
regional respiratory system compliance
Time Frame: 60 minutes after prone positioning
respiratory parameters measured by EIT device
60 minutes after prone positioning
regional respiratory system compliance
Time Frame: 10 minutes after intubation
respiratory parameters measured by EIT device
10 minutes after intubation
overdistension or atelectasis
Time Frame: 10 minutes after intubation
respiratory parameters measured by EIT device
10 minutes after intubation
overdistension or atelectasis
Time Frame: 60 minutes after prone positioning
respiratory parameters measured by EIT device
60 minutes after prone positioning
end-expiratory lung volume
Time Frame: 10 minutes after intubation
respiratory parameters measured by EIT device
10 minutes after intubation
end-expiratory lung volume
Time Frame: 60 minutes after prone positioning
respiratory parameters measured by EIT device
60 minutes after prone positioning
end-expiratory lung impedance
Time Frame: 10 minutes after intubation
respiratory parameters measured by EIT device
10 minutes after intubation
end-expiratory lung impedance
Time Frame: 60 minutes after prone positioning
respiratory parameters measured by EIT device
60 minutes after prone positioning
regional ventilation delay
Time Frame: 10 minutes after intubation
respiratory parameters measured by EIT device
10 minutes after intubation
regional ventilation delay
Time Frame: 60 minutes after prone positioning
respiratory parameters measured by EIT device
60 minutes after prone positioning
center of ventilation
Time Frame: 10 minutes after intubation
respiratory parameters measured by EIT device
10 minutes after intubation
center of ventilation
Time Frame: 60 minutes after prone positioning
respiratory parameters measured by EIT device
60 minutes after prone positioning
vital signs
Time Frame: 10 minutes after intubation
blood pressure (mmHg)
10 minutes after intubation
vital signs
Time Frame: 60 minutes after prone positioning
blood pressure (mmHg)
60 minutes after prone positioning
vital signs
Time Frame: 10 minutes after intubation
oxygen saturation (%)
10 minutes after intubation
vital signs
Time Frame: 60 minutes after prone positioning
oxygen saturation (%)
60 minutes after prone positioning
vital signs
Time Frame: 10 minutes after intubation
heart rate (BPM)
10 minutes after intubation
vital signs
Time Frame: 60 minutes after prone positioning
heart rate (BPM)
60 minutes after prone positioning
arterial blood gas analysis, if patients has arterial catheter
Time Frame: 10 minutes after intubation & 60 minutes after prone positioning
oxygen and cardon dioxide tension
10 minutes after intubation & 60 minutes after prone positioning

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hee-Soo Kim, MD.Ph.D., Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 17, 2022

Primary Completion (ANTICIPATED)

December 31, 2023

Study Completion (ANTICIPATED)

August 31, 2024

Study Registration Dates

First Submitted

January 6, 2023

First Submitted That Met QC Criteria

February 3, 2023

First Posted (ESTIMATE)

February 14, 2023

Study Record Updates

Last Update Posted (ESTIMATE)

February 14, 2023

Last Update Submitted That Met QC Criteria

February 3, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2208-091-1351

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe